Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 2Phase 2 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 28Terminated 6Recruiting 3Unknown 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Hematologic Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Cholecalciferol × Clear all
NCT03320915 2017-10-25

Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT

Seoul National University Hospital

Phase 2 Unknown
88 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00741364 2011-09-30

DProstate

University of Toronto

Phase 2 Unknown
90 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡